NZ527622A - Human orphan G-protein-coupled receptors - Google Patents

Human orphan G-protein-coupled receptors

Info

Publication number
NZ527622A
NZ527622A NZ527622A NZ52762299A NZ527622A NZ 527622 A NZ527622 A NZ 527622A NZ 527622 A NZ527622 A NZ 527622A NZ 52762299 A NZ52762299 A NZ 52762299A NZ 527622 A NZ527622 A NZ 527622A
Authority
NZ
New Zealand
Prior art keywords
amino acid
protein
seq
host cell
acid sequence
Prior art date
Application number
NZ527622A
Other languages
English (en)
Inventor
Ruoping Chen
Huong T Dang
Chen W Liaw
I-Lin Lin
Original Assignee
Arena Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharm Inc filed Critical Arena Pharm Inc
Priority to NZ537625A priority Critical patent/NZ537625A/en
Publication of NZ527622A publication Critical patent/NZ527622A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ527622A 1998-11-20 1999-10-13 Human orphan G-protein-coupled receptors NZ527622A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ537625A NZ537625A (en) 1998-11-20 1999-10-13 Human orphan G protein-coupled receptors of nucleotide and peptide SEQ ID NOS: 13 and 14

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US10921398P 1998-11-20 1998-11-20
US12041699P 1999-02-16 1999-02-16
US12185299P 1999-02-26 1999-02-26
US12394699P 1999-03-12 1999-03-12
US12394999P 1999-03-12 1999-03-12
US13643699P 1999-05-28 1999-05-28
US13643999P 1999-05-28 1999-05-28
US13712799P 1999-05-28 1999-05-28
US13713199P 1999-05-28 1999-05-28
US13656799P 1999-05-28 1999-05-28
US13643799P 1999-05-28 1999-05-28
US14144899P 1999-06-29 1999-06-29
US15663399P 1999-09-29 1999-09-29
US15665399P 1999-09-29 1999-09-29
US15663499P 1999-09-29 1999-09-29
US15655599P 1999-09-29 1999-09-29
US15728299P 1999-10-01 1999-10-01
US15728199P 1999-10-01 1999-10-01
US15728099P 1999-10-01 1999-10-01
US15729499P 1999-10-01 1999-10-01
US15729399P 1999-10-01 1999-10-01
US41676099A 1999-10-12 1999-10-12
US41704499A 1999-10-12 1999-10-12

Publications (1)

Publication Number Publication Date
NZ527622A true NZ527622A (en) 2005-03-24

Family

ID=27586698

Family Applications (3)

Application Number Title Priority Date Filing Date
NZ527622A NZ527622A (en) 1998-11-20 1999-10-13 Human orphan G-protein-coupled receptors
NZ537625A NZ537625A (en) 1998-11-20 1999-10-13 Human orphan G protein-coupled receptors of nucleotide and peptide SEQ ID NOS: 13 and 14
NZ511087A NZ511087A (en) 1998-11-20 1999-10-13 Human orphan G protein-coupled receptors

Family Applications After (2)

Application Number Title Priority Date Filing Date
NZ537625A NZ537625A (en) 1998-11-20 1999-10-13 Human orphan G protein-coupled receptors of nucleotide and peptide SEQ ID NOS: 13 and 14
NZ511087A NZ511087A (en) 1998-11-20 1999-10-13 Human orphan G protein-coupled receptors

Country Status (12)

Country Link
EP (8) EP1849866B1 (cg-RX-API-DMAC7.html)
JP (5) JP2003534767A (cg-RX-API-DMAC7.html)
KR (5) KR100765039B1 (cg-RX-API-DMAC7.html)
AT (3) ATE301673T1 (cg-RX-API-DMAC7.html)
AU (2) AU770056B2 (cg-RX-API-DMAC7.html)
CA (2) CA2348377C (cg-RX-API-DMAC7.html)
DK (3) DK1133559T3 (cg-RX-API-DMAC7.html)
ES (3) ES2289610T3 (cg-RX-API-DMAC7.html)
IL (2) IL142538A0 (cg-RX-API-DMAC7.html)
NZ (3) NZ527622A (cg-RX-API-DMAC7.html)
PT (3) PT1584683E (cg-RX-API-DMAC7.html)
WO (1) WO2000031258A2 (cg-RX-API-DMAC7.html)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69938015T2 (de) * 1998-03-12 2009-01-15 Astellas Pharma Inc. Neue G Protein-gekoppelte Rezeptorproteine
US6071722A (en) * 1998-04-24 2000-06-06 Smithkline Beecham Corporation Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
JP2002512780A (ja) * 1998-04-24 2002-05-08 スミスクライン ビーチャム コーポレーション 新規７ｔｍ受容体ａｘｏｒ−２のクローニング
EP1155031A4 (en) * 1998-11-03 2002-11-27 Smithkline Beecham Corp G PROTEIN TORQUE RECEPTOR, SAID AXOR-14
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
WO2000050458A1 (en) * 1999-02-26 2000-08-31 Smithkline Beecham Corporation Cloning of a p2y-like 7tm receptor (axor17)
US6620615B1 (en) 1999-04-23 2003-09-16 Curagen Corporation G-protein coupled receptor—encoding nucleic acids
EP1189944A4 (en) * 1999-06-21 2002-09-11 Smithkline Beecham Corp AXOR16, R CEPTEUR COUPL UNE PROT INE G
CA2378786A1 (en) * 1999-07-13 2001-01-18 Merck Patent Gesellschaft Mit Beschraenkter Haftung G-protein coupled receptor and dna sequences thereof
EP1198569A1 (en) * 1999-07-30 2002-04-24 MERCK PATENT GmbH G-protein coupled receptor and dna sequences thereof
CA2382889A1 (en) * 1999-08-27 2001-03-08 Takuya Watanabe Novel g protein-coupled receptor protein and dna thereof
US6998255B1 (en) 1999-09-24 2006-02-14 Solvay Pharmaceuticals B.V. Human G-protein coupled receptor
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
US6204017B1 (en) 1999-10-07 2001-03-20 Schering Corporation Polynucleotide encoding a histamine receptor
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9923893D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9924960D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
GB9924956D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
EP1230361A2 (en) * 1999-10-27 2002-08-14 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors expressed in human brain
ATE375390T1 (de) * 1999-10-29 2007-10-15 Pfizer G-protein-gekoppelter rezeptor-ähnliche proteine
WO2001032864A2 (en) * 1999-11-03 2001-05-10 Merck Patent Gmbh Gpcr-kd5 polypeptides and dna sequences thereof
US6461836B1 (en) 1999-11-05 2002-10-08 Smithkline Beecham Corporation Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof
EP1237909A2 (en) * 1999-11-16 2002-09-11 PHARMACIA & UPJOHN COMPANY Human g protein-coupled receptors
US7029857B1 (en) 1999-12-17 2006-04-18 H. Lundbeck A/S Processes for obtaining compounds employing SNORF72 receptors
WO2001046414A1 (fr) * 1999-12-20 2001-06-28 Banyu Pharmaceutical Co., Ltd. Nouvelle proteine receptrice couplee a la proteine de fixation de guanosine triphosphate, bg26
WO2001046454A1 (en) 1999-12-23 2001-06-28 Cor Therapeutics, Inc. P2y12 receptor
AU2230401A (en) * 1999-12-28 2001-07-09 Helix Research Institute Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same
GB0001700D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Novel protein
US7138249B2 (en) 2000-02-04 2006-11-21 Takeda Pharmaceutical Company Limited Screening method
EP1266005B1 (en) * 2000-03-14 2007-03-07 Bayer HealthCare AG Regulation of human lipoxin a4 receptor-like protein
AU3930201A (en) * 2000-03-17 2001-09-24 Bayer Aktiengesellschaft Regulation of human leukotriene B4-like G protein-coupled receptor
AU2001241156A1 (en) * 2000-03-21 2001-10-03 Yamanouchi Pharmaceutical Co..Ltd. Novel leukotriene b4 receptor
US20030087287A1 (en) * 2000-03-28 2003-05-08 Masanori Miwa Novel g-protein-coupled receptor protein and dna thereof
AU4467301A (en) * 2000-03-31 2001-10-08 Helix Research Institute Novel guanosine triphosphate-binding protein-coupled receptor gprv53, gene thereof and production and use of the same
AU2001248755A1 (en) * 2000-04-12 2001-10-23 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
EP1178110A1 (en) * 2000-08-01 2002-02-06 Aventis Pharma Deutschland GmbH EDG8 receptor for sphingosine 1-phosphate , its preparation and use
AU6744501A (en) * 2000-05-18 2001-11-26 Bayer Aktiengesellschaft Regulation of human dopamine-like g protein-coupled receptor
WO2002000719A2 (en) * 2000-06-23 2002-01-03 Tularik Inc. Human and mouse g-protein couipled receptors
AU2001281862A1 (en) * 2000-06-26 2002-01-08 Akzo Nobel N.V. G-protein coupled receptor org10
AU2001281933A1 (en) * 2000-06-30 2002-01-14 Ingenium Pharmaceuticals Ag Human g protein-coupled receptor igpcr17, and uses therof
WO2002004518A2 (en) * 2000-07-06 2002-01-17 Bayer Corporation Human neuropeptide y-like g protein-coupled receptor
EP1311546A2 (en) * 2000-08-09 2003-05-21 Millenium Pharmaceuticals, Inc. Methods for using 14266, a human g protein-coupled receptor
US6790608B2 (en) * 2000-09-20 2004-09-14 The Regents Of The University Of California Methods of identifying and ADP-glucose receptor ligand, agonist or antagonist
ES2282304T3 (es) 2000-11-01 2007-10-16 Astellas Pharma Inc. Procedimiento para seleccionar antiplaquetas.
CA2426037A1 (en) * 2000-11-07 2002-05-16 Paradigm Therapeutics Limited A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
AU2002219890B2 (en) * 2000-11-27 2007-06-14 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human G protein-coupled receptors
EP1338651B9 (en) 2000-12-01 2007-05-09 Astellas Pharma Inc. Method of screening remedy for diabetes
US20020155473A1 (en) * 2000-12-22 2002-10-24 Zaoyuan Peng Methods for identifying G-protein coupled receptors associated with diseases
US7220580B2 (en) 2000-12-22 2007-05-22 University Of South Florida Sphingosine 1-phosphate receptor gene, sppr
GB0100782D0 (en) * 2001-01-11 2001-02-21 Glaxo Group Ltd Assay
JPWO2002088355A1 (ja) * 2001-04-25 2004-08-19 藤沢薬品工業株式会社 新規なグアノシン三リン酸結合タンパク質共役型の受容体ｐｌａｃｅ６００２３１２およびその遺伝子、並びにそれらの製造および用途
US7419658B2 (en) 2001-07-09 2008-09-02 Euroscreen S.A. Isolated ligand of ChemerinR
US7858755B2 (en) 2001-07-09 2010-12-28 Euroscreen S.A. Monoclonal antibodies that bind Chemerin polypeptide
US20030096299A1 (en) 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
US6946244B2 (en) 2001-08-07 2005-09-20 Euroscreen, S.A. Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)
US7338772B2 (en) 2002-04-12 2008-03-04 Schering Corporation G-protein coupled receptor ligands and methods
WO2004022086A1 (ja) * 2002-09-02 2004-03-18 Takeda Pharmaceutical Company Limited 副腎皮質ホルモン分泌調節剤
AU2003271149A1 (en) * 2002-10-11 2004-05-04 Yamanouchi Pharmaceutical Co., Ltd. Method of screening remedy for renal failure
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
CA2509218C (en) 2002-12-20 2010-09-07 Merck & Co., Inc. 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
CN102558155A (zh) 2003-01-14 2012-07-11 阿伦纳药品公司 作为代谢调节剂的芳基和杂芳基衍生物及其所涉及的疾病如糖尿病和高血糖症的预防和治疗
US7083933B1 (en) 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
JP2007526747A (ja) * 2003-06-27 2007-09-20 タノックス インコーポレーテッド ヒトマスト細胞発現膜タンパク質
US7524638B1 (en) 2003-06-27 2009-04-28 Osi Pharmaceuticals, Inc. Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
DOP2006000008A (es) * 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
GB0508990D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
CN103323606A (zh) 2006-04-11 2013-09-25 艾尼纳制药公司 使用gpr119受体鉴定可用于增加个体骨质量的化合物的方法
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
KR20100033419A (ko) 2007-07-19 2010-03-29 메타볼렉스, 인코포레이티드 당뇨병 및 대사 장애의 치료를 위한 ｒｕｐ3 또는 ｇｐｒ119 수용체의 작용제로서 ｎ-아자시클릭 치환된 피롤, 피라졸, 이미다졸, 트리아졸 및 테트라졸 유도체
CA2697551C (en) 2007-09-20 2013-03-12 Irm Llc Piperidine derivatives as modulators of gpr119 activity
EP2146210A1 (en) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
CN102666553B (zh) 2009-10-01 2015-05-06 赛马拜制药公司 取代的四唑-1-基-苯氧基甲基-噻唑-2-基-哌啶基-嘧啶盐
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
US20130023494A1 (en) 2010-04-06 2013-01-24 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
ES2676209T3 (es) 2010-06-23 2018-07-17 Metabolex Inc. Composiciones de 5-etil-2-{4-[4-(4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
BR112013008100A2 (pt) 2010-09-22 2016-08-09 Arena Pharm Inc "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
EP3242666B9 (en) 2015-01-06 2024-12-25 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
IL285890B (en) 2015-06-22 2022-07-01 Arena Pharm Inc Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid
CN109862896A (zh) 2016-08-03 2019-06-07 西玛贝医药公司 用于治疗炎症性胃肠疾病或胃肠病症的氧亚甲基芳基化合物
MA49456A (fr) 2017-06-19 2020-04-29 Arena Pharm Inc Composés et procédés pour le traitement de nafld et de nash
KR102859841B1 (ko) 2018-06-06 2025-09-12 아레나 파마슈티칼스, 인크. S1p1 수용체와 관련된 병태의 치료 방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0868510A2 (en) * 1995-11-15 1998-10-07 Cor Therapeutics, Inc. P2u2 PURINERGIC RECEPTOR
JP2000505644A (ja) * 1996-01-11 2000-05-16 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトｇタンパク質結合レセプター
WO1998031810A2 (en) * 1997-01-21 1998-07-23 Schering Corporation Mammalian chemokines; receptors; reagents; uses
US6221627B1 (en) * 1997-02-24 2001-04-24 Smithkline Beecham Corporation cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor
US5955303A (en) * 1997-03-06 1999-09-21 Incyte Pharmaceuticals, Inc. Human chemokine receptor-like protein
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US6060272A (en) * 1997-05-07 2000-05-09 Human Genome Sciences, Inc. Human G-protein coupled receptors
EP0899332A3 (en) * 1997-08-15 2000-07-05 Smithkline Beecham Corporation The G-protein coupled receptor HFIAO41
CA2239255A1 (en) * 1997-10-23 1999-04-23 Smithkline Beecham Corporation Cdna clone hneaa81 that encodes a human 7-transmembrane receptor
US5932445A (en) * 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins
US6252056B1 (en) * 1997-11-11 2001-06-26 Ono Pharmaceutical Co., Ltd. Human lysophosphatidic acid receptor and use thereof
US6207412B1 (en) * 1997-11-13 2001-03-27 The Regents Of The University Of California Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
EP1054903A4 (en) * 1998-02-20 2002-10-09 Smithkline Beecham Corp FISHBOY, A G PROTEIN COUPLED RECEPTOR
DE69938015T2 (de) * 1998-03-12 2009-01-15 Astellas Pharma Inc. Neue G Protein-gekoppelte Rezeptorproteine
AU3749499A (en) * 1998-04-16 1999-11-01 Millenium Pharmaceuticals, Inc. Novel molecules of the bgckr-related protein family and uses thereof
SE9801455D0 (sv) * 1998-04-24 1998-04-24 Astra Pharma Inc New receptor
JP2002512780A (ja) * 1998-04-24 2002-05-08 スミスクライン ビーチャム コーポレーション 新規７ｔｍ受容体ａｘｏｒ−２のクローニング
US6071722A (en) * 1998-04-24 2000-06-06 Smithkline Beecham Corporation Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
JP2002531057A (ja) * 1998-08-19 2002-09-24 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Ｅｄｇ受容体ファミリーに関連したｇタンパク質結合受容体である１４２７４受容体
JP2003532369A (ja) * 1998-08-20 2003-11-05 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Ｇタンパク質結合受容体である１４４００受容体
CA2340616A1 (en) * 1998-08-24 2000-03-02 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
AU5801099A (en) * 1998-09-02 2000-03-21 Millennium Pharmaceuticals, Inc. 14926 receptor, a novel g-protein coupled receptor
WO2000022131A2 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors
CA2344605A1 (en) * 1998-10-16 2000-04-27 Millennium Pharmaceuticals, Inc. G-protein coupled receptors
EP1127128A1 (en) * 1998-11-04 2001-08-29 Chiron Corporation Isolated vshk-1 receptor polypeptides and methods of use thereof
DE69933688T2 (de) * 1998-11-06 2007-08-23 Bayer Healthcare Ag G-protein-gekoppelter rezeptoren, die holomog zu ebv-induzierter gpcr (ebi-2) sind, verfahren zur identifizierung von ihren entsprechenden liganden
US6221660B1 (en) * 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
US6689866B1 (en) * 1999-03-09 2004-02-10 Curagen Corporation Polynucleotides and proteins encoded thereby
US6590938B1 (en) * 1999-09-30 2003-07-08 Conexant Systems, Inc. DCT domain conversion of a higher definition signal to lower definition signal
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide

Also Published As

Publication number Publication date
NZ511087A (en) 2004-01-30
KR20010086040A (ko) 2001-09-07
EP1849866A2 (en) 2007-10-31
EP1584683A1 (en) 2005-10-12
ATE396400T1 (de) 2008-06-15
PT1849866E (pt) 2008-08-28
EP1133559A2 (en) 2001-09-19
HK1103763A1 (en) 2007-12-28
EP1580271A2 (en) 2005-09-28
ATE301673T1 (de) 2005-08-15
KR20080024234A (ko) 2008-03-17
ES2243095T3 (es) 2005-11-16
EP1580271A3 (en) 2006-01-18
IL142538A (en) 2010-11-30
ES2308759T3 (es) 2008-12-01
HK1037675A1 (en) 2002-02-15
KR20070097564A (ko) 2007-10-04
ES2289610T3 (es) 2008-02-01
KR100926208B1 (ko) 2009-11-09
KR20080024233A (ko) 2008-03-17
JP2007209352A (ja) 2007-08-23
PT1133559E (pt) 2005-10-31
KR100963367B1 (ko) 2010-06-14
KR100765039B1 (ko) 2007-10-09
PT1584683E (pt) 2007-10-17
WO2000031258A3 (en) 2000-10-05
EP2295574A1 (en) 2011-03-16
EP2295573A1 (en) 2011-03-16
EP1849866B1 (en) 2008-05-21
KR100926209B1 (ko) 2009-11-09
EP1780280A1 (en) 2007-05-02
AU2004202147A1 (en) 2004-06-10
JP2003534767A (ja) 2003-11-25
WO2000031258A2 (en) 2000-06-02
AU770056B2 (en) 2004-02-12
CA2348377A1 (en) 2000-06-02
EP2295572A1 (en) 2011-03-16
JP2008133300A (ja) 2008-06-12
CA2348377C (en) 2008-12-02
DK1584683T3 (da) 2007-10-29
EP1133559B1 (en) 2005-08-10
JP2009298791A (ja) 2009-12-24
AU3790400A (en) 2000-06-13
ATE366815T1 (de) 2007-08-15
KR20080104062A (ko) 2008-11-28
DK1849866T3 (da) 2008-09-08
CA2645717A1 (en) 2000-06-02
DK1133559T3 (da) 2006-04-10
EP1584683B1 (en) 2007-07-11
NZ537625A (en) 2006-08-31
EP1849866A3 (en) 2007-11-07
JP2004267216A (ja) 2004-09-30
IL142538A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
EP1133559B1 (en) Human orphan g protein-coupled receptor rup3
US7108991B2 (en) Human orphan G protein-coupled receptors
US8198049B2 (en) Nucleic acids encoding RUP3 and methods of using same
AU2007202139B2 (en) Human Orphan G protein-coupled receptor hRUP3
USRE42190E1 (en) Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
HK1077082A (en) Human orphan g protein-coupled receptors
HK1155771A (en) Human orphan g protein-coupled receptors
HK1098510A (en) Human orphan g protein-coupled receptors
HK1037675B (en) Human orphan g protein-coupled receptor rup3
HK1103763B (en) Human orphan g protein-coupled receptor rup3
HK1077081A1 (en) Human orphan g protein-coupled receptor rup3
HK1077081B (en) Human orphan g protein-coupled receptor rup3
CA2732120A1 (en) Endogenous and non-endogenous versions of human g protein-coupled receptors

Legal Events

Date Code Title Description
PSEA Patent sealed
S35A Application for proceedings under section 35 (restoration of lapsed patents)
RENW Renewal (renewal fees accepted)
S35R Proceedings under section 35 (restoration of lapsed patents): patent restored
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired